MARKET OVERVIEW
Menopause is the end of the fertility stage in women, which occurs at the age of 40 in almost 80% of women. Menopause reduces estrogen production and increases gonadotropin, which leads in the termination of their menstrual flow and cycle. Few of the symptoms that are observed during menopause are hot flashes, formication, and migraine.
MARKET SCOPE
The "Global Menopause Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Menopause market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Menopause market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on hormonal treatment, the global Menopause market is segmented into estrogen, progesterone, combination.
- On the basis of non-hormonal treatment, the market is segmented into anti-depressants, anti-anxiety, anti-migraine
- On the basis of end use, the market is segmented into hospitals and clinics, academic and research, institutes, others.
MARKET DYNAMICS
Drivers:
- Rise in the incidences of several menopausal symptoms.
- Rise in the awareness about menopause and its treatment.
- Increasing research supporting advantages of dietary supplements.
Restraints:
- The lack of advanced healthcare infrastructure in developing countries is the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Menopause market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Menopause market in these regions.
IMPACT OF COVID-19 ON MENOPAUSE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Menopause market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Menopause market are anticipated to lucrative growth opportunities in the future with the rising demand for Menopause in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Menopause market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Merck & Co.Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Allergan plc
- Emcure Pharmaceuticals Ltd.
- Eli Lilly and Company
- Cipla Inc.
- Teva Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd
Menopause Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Hormonal Treatment
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Sleep Apnea Diagnostics Market
- Bathroom Vanities Market
- Fixed-Base Operator Market
- Dry Eye Products Market
- Rugged Servers Market
- Quantitative Structure-Activity Relationship (QSAR) Market
- Asset Integrity Management Market
- Micro-Surgical Robot Market
- Nuclear Decommissioning Services Market
- Airline Ancillary Services Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Merck & Co.Inc.
2. Novartis AG
3. Novo Nordisk A/S
4. Pfizer Inc.
5. Allergan plc
6. Emcure Pharmaceuticals Ltd.
7. Eli Lilly and Company
8. Cipla Inc.
9. Teva Pharmaceutical Industries Ltd.
10. Glenmark Pharmaceuticals Ltd
11. Abbott Laboratories
1. Merck & Co.Inc.
2. Novartis AG
3. Novo Nordisk A/S
4. Pfizer Inc.
5. Allergan plc
6. Emcure Pharmaceuticals Ltd.
7. Eli Lilly and Company
8. Cipla Inc.
9. Teva Pharmaceutical Industries Ltd.
10. Glenmark Pharmaceuticals Ltd
11. Abbott Laboratories